CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway (scientific article published on 21 September 2019)

scientific article published on 21 September 2019

CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway is …

instance of (P31):

scholarly article

Q13442814

External links are

P356	DOI	10.1007/S10585-019-09993-Y
P698	PubMed publication ID	31541326

P50

author

Fumitaka Kikkawa

Q89568553

P2093

author name string

Yang Peng

Hiroaki Kajiyama

Kae Nakamura

Shiro Suzuki

Nobuhisa Yoshikawa

Satoshi Tamauchi

Hiroaki Yasui

Mai Sugiyama

P2860

cites work

The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor

Q24316405

The preclinical natural history of serous ovarian cancer: defining the target for early detection

Q33487678

Annual Report of the Committee on Gynecologic Oncology, Japan Society of Obstetrics and Gynecology: Patient Annual Report for 2013 and Treatment Annual Report for 2008.

Q51312579

Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors.

Q51633169

MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.

Q55026460

Genetic Evidence for Early Peritoneal Spreading in Pelvic High-Grade Serous Cancer.

Q55247640

Prognostic factors in epithelial ovarian cancer: A population-based study.

Q55315651

Possible involvement of SDF-1alpha/CXCR4-DPPIV axis in TGF-beta1-induced enhancement of migratory potential in human peritoneal mesothelial cells

Q81230145

Chemokines in tumor progression and metastasis

Q86814803

The roles of TGFβ in the tumour microenvironment

Q33630845

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Q34121226

The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer

Q34219670

The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion

Q35108960

Multidetector CT of Peritoneal Carcinomatosis from Ovarian Cancer

Q35124938

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer

Q35858991

CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells

Q36007881

CCL2/CCR2 Chemokine Signaling Coordinates Survival and Motility of Breast Cancer Cells through Smad3 Protein- and p42/44 Mitogen-activated Protein Kinase (MAPK)-dependent Mechanisms

Q36332973

Advances in treatment of epithelial ovarian cancer

Q36437027

Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response

Q36528201

Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients

Q36640987

Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment

Q37051364

Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs.

Q37337898

Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma

Q37437275

7-(O)-Carboxymethyl daidzein conjugated to N-t-Boc-hexylenediamine: a novel compound capable of inducing cell death in epithelial ovarian cancer stem cells

Q37441283

Chemokine receptors in epithelial ovarian cancer

Q37535454

Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling

Q37559049

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

Q37594369

TGF-β signalling and its role in cancer progression and metastasis

Q38020111

CCL2-CCR2 Signaling in Disease Pathogenesis

Q38378524

Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways

Q38769001

CCL2 promotes integrin-mediated adhesion of prostate cancer cells in vitro

Q38960744

MCP-1 promotes invasion and adhesion of human ovarian cancer cells

Q39063837

CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration

Q39127265

The Unique Molecular and Cellular Microenvironment of Ovarian Cancer

Q39169603

Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway

Q39315794

CCL2 expression in primary ovarian carcinoma is correlated with chemotherapy response and survival outcomes

Q39615263

Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness

Q39668916

CCL2 at the crossroad of cancer metastasis

Q42136303

Global Cancer in Women: Burden and Trends

Q44404178

Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.

Q45283850

Expression of the miR200 family of microRNAs in mesothelial cells suppresses the dissemination of ovarian cancer cells

Q46538151

CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway

Q49187592

A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-β derived from ovarian cancer

Q49384884

CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer

Q49888066

Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement

Q49951147

P433

issue

P921

main subject

ovarian cancer

Q172341

P304